Full Year 2025 Straumann Holding AG Earnings Call Transcript
Key Points
- Straumann Holding AG (SAUHF) achieved a strong revenue growth of CHF2.6 billion in 2025, representing an organic growth of 8.9%.
- The company launched a record number of new products in 2025, with the iEXCEL implant becoming the most successful implant launch in its history.
- Straumann Holding AG (SAUHF) reported a core EBIT margin increase to 26.5% at constant currency rates, demonstrating resilience and disciplined execution.
- The company expanded its market share in key segments, increasing its total share from 12.5% to 14% within the last 12 months.
- Straumann Holding AG (SAUHF) generated a free cash flow of CHF290 million, reflecting strong operating performance and effective working capital management.
- The company faced currency and tariff headwinds, which impacted revenue growth in Swiss francs, resulting in a reported growth of only 4.1%.
- Performance in China was significantly impacted by a softer patient flow and distributor destocking behavior, particularly linked to the upcoming GDP process.
- The financial results were slightly lower compared to the prior year due to the effects of currency hedging and higher taxes.
- The transition of clear aligner production to Smartee has not yet had a meaningful impact on EBIT margin in 2025.
- The company experienced a visible impact on profitability due to FX effects, with revenue growth differing by around 480 basis points between local currencies and Swiss francs.
(Operator Instructions) Ladies and gentlemen, welcome to the Straumann Group full-year 2025 results conference call and live webcast. (Operator Instructions) the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it is my pleasure to hand over to Guillaume Daniellot, CEO. Please go ahead, sir.
Thank you, and good morning or afternoon to all of you. Thank you for attending this conference call under Straumann group's full-year 2025 results. Please take note of the disclaimer in our media release and on slide 2. During this conference call, we are going to refer to the presentation slides that were published on our website this morning. As usual, the discussion will include some forward-looking statements.
As shown on slide 3, I will start with the 2025 performance overview. Isabelle will then cover the financial details. And afterwards, I will share
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
